Viewing Study NCT05565794

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-06-17 @ 11:12 AM
Study NCT ID: NCT05565794
Status: TERMINATED
Last Update Posted: 2025-04-13
First Post: 2022-09-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intrahepatic Cholangiocarcinoma View
None FGFR2 Gene Mutation View
None FGFR2 Gene Rearrangement View
None FGFR2 Gene Translocation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None intrahepatic cholangiocarcinoma View
None iCCA View
None FGFR2 fusion View
None FGRF2 rearrangement View
None FGFR2 alteration View
None FGFR2 mutation View